What is he best known for?
The fields of study he is best known for:
Immunology, Molecular biology, Hepatitis C virus, Virus and Cell biology are his primary areas of study.
His Immunology research is multidisciplinary, incorporating perspectives in Apoptosis and Cancer research.
His Molecular biology research is multidisciplinary, relying on both Phosphoprotein, Gene, Transfection, Small nuclear RNA and Splenocyte.
His Virus research is within the category of Virology.
His Virology research includes themes of Plasmid, DNA vaccination, Antibody and Heterologous.
His biological study spans a wide range of topics, including Cell cycle checkpoint, Cytotoxic T cell, In vitro, Cytokine and In vivo.
His most cited work include:
- Local structural elements in the mostly unstructured transcriptional activation domain of human p53. (265 citations)
- STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice (259 citations)
- Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability (149 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Virology, Immune system, Molecular biology and DNA vaccination.
His work is dedicated to discovering how Immunology, Cytotoxic T cell are connected with Cell biology and other disciplines.
His work carried out in the field of Virology brings together such families of science as Plasmid, Antibody and Recombinant DNA.
In his study, Mesenchymal stem cell, Cancer immunotherapy and Pathology is strongly linked to Cancer research, which falls under the umbrella field of Immune system.
His Molecular biology study combines topics from a wide range of disciplines, such as Long terminal repeat and Fusion protein.
His research integrates issues of CD8 and Cytokine in his study of T cell.
He most often published in these fields:
- Immunology (32.29%)
- Virology (31.77%)
- Immune system (25.00%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (7.29%)
- Immune system (25.00%)
- Cancer research (13.02%)
In recent papers he was focusing on the following fields of study:
Young Chul Sung mainly investigates Internal medicine, Immune system, Cancer research, Cell biology and Pharmacology.
His research combines Myeloid and Immune system.
The concepts of his Cancer research study are interwoven with issues in Mesenchymal stem cell, Combination therapy, Bone morphogenetic protein 2 and Cancer immunotherapy.
The study incorporates disciplines such as B cell and Genetically modified organism in addition to Cell biology.
His study in Pharmacology is interdisciplinary in nature, drawing from both Antibody and Anemia.
His CD8 study combines topics in areas such as Vaccination, Virology, Immunization, DNA vaccination and Viral load.
Between 2017 and 2021, his most popular works were:
- A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3 (14 citations)
- Bone marrow CX3CR1+ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in mice. (8 citations)
- Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial. (7 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Internal medicine, Immune system, Cancer research, Cancer immunotherapy and Granzyme B.
All of his Immune system and Immunization and DNA vaccination investigations are sub-components of the entire Immune system study.
His Cancer research study integrates concerns from other disciplines, such as Cell culture, Leukocyte proliferation, Natural killer cell, Cytotoxic T cell and Flow cytometry.
His Cancer immunotherapy research includes elements of Immune checkpoint, Innate immune system and Tumor microenvironment.
Young Chul Sung combines subjects such as Pharmacokinetics, Pharmacodynamics, Immunogenicity and Immunoglobulin D with his study of Adverse effect.
His work deals with themes such as Ex vivo, ELISPOT, Cervical intraepithelial neoplasia and Randomization, which intersect with Clinical endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
